https://www.selleckchem.com/products/ipi-549.html
Among these new biomarkers we have to report sirtuins, microRNAs, ST2 protein, apolipoprotein E protein, adiponectin and others. These biomarkers are preferentially expressed locally in the target tissue of inflammation, but also released in peripheral blood and then used as diagnostic and prognostic biomarkers. Indeed, these biomarkers might also predict future adverse cardiovascular events and worse prognosis in patients with CVD. Furthermore, these new inflammatory biomarkers can also be analyzed to evaluate therapeutic efficacy in p
Aimer
Commentaire
Partagez
